Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

RNA-sequencing reveals oligodendrocyte and neuronal transcripts in microglia relevant to central nervous system disease.
Short Peptide Type I Interferon Mimetics; Therapeutics for Experimental Allergic Encephalomyelitis, Melanoma, and Viral Infections.
High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991-2010).
Allogeneic Hematopoietic Stem Cell Transplantation for Neuromyelitis Optica.
The primary vascular dysregulation syndrome: implications for eye diseases.
Symptoms and Association with Health Outcomes in Relapsing-Remitting Multiple Sclerosis: Results of a US Patient Survey.
Expression of semaphorin 3A, semaphorin 7A and their receptors in multiple sclerosis lesions.
Multiple sclerosis patients and clinical care in Taiwan.
Antineutrophil Cytoplasmic Antibodies in Patients with Idiopathic Inflammatory-Demyelinating Diseases.
Microglia and necroptosis: The culprits of neuronal cell death in multiple sclerosis.
Quantification of retinal neural loss in patients with neuromyelitis optica and multiple sclerosis with or without optic neuritis using optical coherence tomography.
Multimodal noninvasive and invasive imaging of extracranial venous abnormalities indicative of CCSVI: results of the PREMiSe pilot study.
Response to letter regarding article 'Fingolimod effects on left ventricular function in multiple sclerosis'.
Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis.
Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.
Progressive multifocal leukoencephalopathy: cavitary white matter lesions.
Available evidence and outcome of off-label use of rituximab in clinical practice.
[Clinical significance of the cardiovascular effects of fingolimod treatment in multiple sclerosis].
Assessment of ovarian reserve and Doppler characteristics in patients with multiple sclerosis using immunomodulating drugs.
Environmental factors and multiple sclerosis severity: a descriptive study.
Age-associated changes in rat immune system: Lessons learned from experimental autoimmune encephalomyelitis.
Inflammatory cytokines at the summits of pathological signal cascades in brain diseases.
Computer-Assisted Cognitive Rehabilitation of Attention Deficits for Multiple Sclerosis: A Randomized Trial With fMRI Correlates.
The primate autoimmune encephalomyelitis model; a bridge between mouse and man.
β-Arrestins 1 and 2 are critical regulators of inflammation.

Pages